dr. lemieux and then for dr. peters. i appreciate your comments regarding the need for what i consider applied biosafety research for waste decontamination systems including 80 of come a digestive and others. but how do you develop the risk assessment justification and explanation to the lay public on some the technical nuances that we have and sterilization, reduction versus decontaminati decontamination, reducing to an acceptable level, et cetera, as folks grapple with the theaters of how well incinerators incinerate a virus for example? and then to follow on, dr. peters, how well-developed are many genome systems and viruslike particle systems or other systems or using rest and ebola as a model in terms of polling that work out of the biosafety level for containment and to biosafety level 2, including the use of -- some of the experiments dr. lemieux described? >> well, i think the whole issue of risk mitigation. i didn't have it on my slide but i should have. it's a huge gap i think across the whole spectrum of every

lemieux, was with the epa office of research and development. the national homeland security research center. welcome. >> thank you, dr. goldman. i'm honored to be your. i am primarily -- i am honored to be here. i am primarily going to be talking about treatment waste, but this is a big incident that involves many different considerations that impact other considerations like how infection ach the control affects how the waste is generated. so everything affects everything else in the be uation and we need to able to -- to be thinking about all of them at the same time. talk about waste management, there is a number steps two waste management, some of which can result in potential exposure to the waste management workers. and there are technical of ues associated with some them as well. i'm going to focus on the aspect of it, but people need to remember that package e people who truck uff up, there are drivers who transported, when it arrives at the treatment facility, they may have to open up the packages. dot has fairly stringent to package s for how category a bioagents. then you have to transport to your ultimate disposal

lemieux, epa office of research and development. their national homeland security research center, and consequence management decisions. welcome. >> thank you, dr. goldman. i'm honored to be here. i'm primarily going to be talking about treatment of waste. this is a big integrated incident that involves many different considerations that impact other considerations like how they approach infection control affects how the waste is generated. what disinfect ants you use is affects how the waste is generated. everything affects everything else in this situation and we need to think about all of them at the same time. when people talk about waste management, there's a number of steps of waste management. some of which can result in potential exposure to the waste management workers. and there is technical issues associated with some of them as well. i'm going to focus on the treatment aspect of it but people need to remember that there is people that package this stuff up. there is truck drivers that transport it, when it arrives at the treatment facility. they may have to open up the packages. d.o.t. has fairly stringent requirements how to packag